# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate intraoperative cell therapies

## SUMMARY OF THE INVENTION

- introduce aptamer-based cell isolation
- describe device for enriching cells
- outline method for enriching cells
- summarize cell-based therapy
- describe kit for cell enrichment

## DETAILED DESCRIPTION OF THE INVENTION

- introduce cell enrichment device using aptamers
- describe mechanism of cell release using mechanical forces
- highlight application in intraoperative cell enrichment for bone healing

### I. CD31+ Cells

- describe CD31+ cells and their properties

### II. Aptamers

- define aptamers and their properties
- describe advantages of aptamers over antibodies
- outline SELEX process for generating aptamers
- describe Counter-SELEX for improving aptamer specificity
- discuss tags and probes for attaching aptamers to solid supports

### III. Devices for Enrichment of Cells

- describe device for enriching cell population with cells expressing cell surface marker
- specify aptamer capable of specifically binding cell surface marker
- detail bead characteristics and optional filter and column components
- list exemplary cell surface markers suitable for use in the invention
- describe bead size and column volume options
- explain advantages of using beads larger than cell diameter
- outline methods for releasing captured cells from beads
- discuss device portability and prepackaging in a sterile container

### IV. Methods of Enriching Cells from a Mixed Cell Population

- provide methods for enriching cells
- describe aptamer-coupled beads
- outline contacting aptamer-coupled beads with mixed cell population
- detail washing and releasing bound cells
- specify incubation time and temperature
- describe releasing cells using mechanical force
- outline releasing cells using temperature change
- describe releasing cells using complementary nucleic acid
- specify column and filter sizes
- detail bead composition and size
- describe aptamer coupling and loading

### V. Kits

- describe kit components
- specify kit features and uses

### VI. Methods of Treatment

- provide cell-based therapy methods
- describe cell enrichment and isolation methods
- outline administration methods for enriched cells
- specify applications of the methods
- define angiogenesis-related diseases
- define osteogenesis-related diseases
- define bone-fracture and related conditions
- define immunomodulation-related diseases
- describe treatment methods
- formulate cells with carrier
- administer cells to subject

## EXAMPLES

### Materials and methods

- prepare PBMCs
- validate aptamer specificity
- perform magnetic bead studies
- assemble system components

### Aptamer Selection and Validation

- perform 2D cell adhesion assay
- validate aptamer specificity

### Development of a CD31+ Cell Enrichment System

- describe system characteristics
- outline enrichment procedure
- optimize system parameters

### CD31+ Enriched Cell Populations

- validate system for enrichment of CD31+ cells

### Angiogenic and Osteogenic Potential of CD31+ Enriched Cell Populations

- assess angiogenic potential using tube formation assay
- evaluate osteogenic potential using Alizarin red staining
- analyze CD31+ cell composition before and after isolation
- determine angiogenic and osteogenic potential of enriched CD31+ cells
- confirm maintenance of key functions in enriched CD31+ cells

## EQUIVALENTS

- disclaim limitations

